Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis [Phase 4]
This open-label Phase 4 study evaluated safety and pharmacokinetics of the DUEXIS ibuprofen/famotidine tablet in children with Juvenile Idio…
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: The CARRA Registry
The CARRA Registry study sponsored by Duke University has completed, documenting a broad range of juvenile rheumatic diseases, including Juv…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects [Phase 4]
Phase 4 study evaluating the effects of celecoxib versus naproxen on blood pressure in pediatric arthritis patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis [Phase 3]
Phase 3 clinical trial evaluating an aggressive combination therapy for very early polyarticular juvenile idiopathic arthritis has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study [Phase 3]
Long-term extension study of tocilizumab (RoActemra/Actemra) in children with Juvenile Idiopathic Arthritis who completed the core WA19977 s…
-
FDA approval · 2015-09-23FDA Approved: CELECOXIB — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Celecoxib under an Original Application for generic Celecoxib. The approval covers multiple indications common…
-
CLINICAL_TRIALS research · 2015-09-07Clinical Trial Update: Biomarkers in Idiopathic Juvenile Arthritis [NA]
An update on a clinical trial evaluating biomarkers in juvenile idiopathic arthritis; current trial status is unknown.
-
FDA approval · 2015-08-24FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen by Hikma Pharmaceuticals USA Inc., indicating changes to the product's approval.
-
FDA approval · 2015-08-21FDA Approved: CELECOXIB — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for a generic Celecoxib product. This marks the entry of a generic celecoxib into…
-
FDA approval · 2015-07-01FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Meloxicam, a generic NSAID, confirming continued availability of the pr…
-
FDA approval · 2015-06-19FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) submitted by Pfizer Laboratories Div Pfizer Inc. The approval updates the …
-
FDA approval · 2015-06-09FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' Original Application for celecoxib, enabling a generic version of Celecoxib to enter the market.
-
FDA approval · 2015-03-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept), expanding its label with additional indications. The submission status indi…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis [NA]
A clinical trial evaluating gamma-linolenic acid for juvenile idiopathic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders [Phase 1]
Completed Phase 1 pilot study evaluating total body irradiation with cyclophosphamide, anti-thymocyte globulin, and autologous CD34-selected…
-
FDA approval · 2014-11-28FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for a diclofenac sodium product manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2014-11-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …
-
FDA approval · 2014-10-29FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic version of celecoxib (Celecoxib) under an original ANDA.
-
FDA approval · 2014-10-08FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for OTREXUP (methotrexate) submitted by Antares Pharma, Inc.
-
FDA approval · 2014-09-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved Humira's supplemental application submitted by Cordavis Limited. The approval acts as a supplemental approval to the existing H…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS) [Phase 3]
This Phase 3 trial assessed golimumab in children with juvenile idiopathic arthritis who had poor response to methotrexate; the study was te…
-
FDA approval · 2014-09-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) to add Cordavis Limited as a supplier. This action supports continued av…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
This is a completed all-case surveillance trial assessing Enbrel (etanercept) use in Juvenile Idiopathic Arthritis, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis [Phase 4]
Phase 4 study assessing the safety and efficacy of the Measles, Mumps, and Rubella vaccine in patients with juvenile idiopathic arthritis.